(Q42279293)

English

Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

scientific article published on 5 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

author name string

J Casey

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

K Morris

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

M Narayana

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

M Nakagaki

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

G A Kennedy

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

5 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1558-1561

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2013.112

0 references

An outbreak of respiratory syncytial virus in a bone marrow transplant center

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Low mortality rates related to respiratory virus infections after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

21 January 2018

Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.112

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2013.112

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42279293&oldid=1940963552"